48
Views
5
CrossRef citations to date
0
Altmetric
Patent Evaluation

CB1 cannabinoid receptor antagonism for treating inflammation and arthritis

Pfizer: WO2007039797

, PhD
Pages 1027-1031 | Published online: 16 Aug 2007

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Mayank Kumar Sharma, Prashant R Murumkar, Mahesh A Barmade, Rajani Giridhar & Mange Ram Yadav. (2015) A comprehensive patents review on cannabinoid 1 receptor antagonists as antiobesity agents. Expert Opinion on Therapeutic Patents 25:10, pages 1093-1116.
Read now

Articles from other publishers (4)

Riadh Hanachi, Ridha Ben Said, Hamza Allal, Seyfeddine Rahali, Mohammed A. M. Alkhalifah, Faisal Alresheedi, Bahoueddine Tangour & Majdi Hochlaf. (2021) Structural, QSAR, machine learning and molecular docking studies of 5-thiophen-2-yl pyrazole derivatives as potent and selective cannabinoid-1 receptor antagonists. New Journal of Chemistry 45:38, pages 17796-17807.
Crossref
Annapurna Pendri, Dharmpal S. Dodd, Jing Chen, Mary Ellen Cvijic, Liya Kang, Rose A. Baska, Kenneth E. Carlson, Neil T. Burford, Chongqing Sun, William R. Ewing & Samuel W. Gerritz. (2012) Solid Phase Synthesis of 1,5-Diarylpyrazole-4-carboxamides: Discovery of Antagonists of the CB-1 Receptor. ACS Combinatorial Science 14:3, pages 197-204.
Crossref
Shi-Liang Tseng, Ming-Shiu Hung, Chun-Ping Chang, Jen-Shin Song, Chia-Liang Tai, Hua-Hao Chiu, Wan-Ping Hsieh, Yinchiu Lin, Wan-Ling Chung, Chun-Wei Kuo, Chien-Huang Wu, Cheng-Ming Chu, Yen-Shih Tung, Yu-Sheng Chao & Kak-Shan Shia. (2008) Bioisosteric Replacement of the Pyrazole 5-Aryl Moiety of N -(Piperidin-1-yl)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1 H -pyrazole-3-carboxamide (SR141716A). A Novel Series of Alkynylthiophenes as Potent and Selective Cannabinoid-1 Receptor Antagonists . Journal of Medicinal Chemistry 51:17, pages 5397-5412.
Crossref
Jos H. M. Lange & Chris G. Kruse. (2008) Cannabinoid CB 1 receptor antagonists in therapeutic and structural perspectives . The Chemical Record 8:3, pages 156-168.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.